Lv3
340 积分 2024-07-17 加入
The SGLT2 inhibitor dapagliflozin ameliorates renal fibrosis in hyperuricemic nephropathy
17小时前
已完结
Gout Flares and Mortality After Sodium-Glucose Cotransporter-2 Inhibitor Treatment for Gout and Type 2 Diabetes
17小时前
已完结
Is colchicine prophylaxis required with start-low go-slow allopurinol dose escalation in gout? A non-inferiority randomised double-blind placebo-controlled trial
17小时前
已完结
Association of Dapagliflozin Use With Clinical Outcomes and the Introduction of Uric Acid–Lowering Therapy and Colchicine in Patients With Heart Failure With and Without Gout
18小时前
已完结
How common are side effects of treatment to prevent gout flares when starting allopurinol?
18小时前
已完结
Teclistamab-Induced Remission in Refractory Systemic Lupus Erythematosus
2个月前
已完结
Kidney Involvement in Systemic Lupus Erythematosus (SLE): Beyond Lupus Nephritis
2个月前
已完结
Achievable but elusive: LLDAS and DORIS remission in clinical trials of belimumab
2个月前
已完结
Serum Urate and Recurrent Gout
5个月前
已完结
The Efficacy of L-glutamine in Osteoarthritis:a comparative analysis with celecoxib and glucosamine sulfate
5个月前
已完结
皖公网安备34019202002308
